BRIANNA BELDEN: Open Payments
NPI 1952084428 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$265 in 8 payments from 3 companies in 2025. Trend: 2023 $30 · 2024 $164 · 2025 $265
Food & beverage: $265
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 6 | $177 |
| REVANCE THERAPEUTICS, INC. | 1 | $76 |
| Boston Scientific Corporation | 1 | $12 |
Products named: Veozah, DAXXIFY, Axonics.
Industry payments across OK — which companies pay providers there.
